Meril Life Sciences, a leading global med-tech company with its portfolio in cardiovascular and structural heart solutions, celebrated a remarkable achievement with the launch of its cutting-edge Myval Octapro Transcatheter Heart Valve (THV) at GISE 2024 (National Congress of the Italian Society of Interventional Cardiology)
The LANDMARK randomised controlled trial (RCT) for MYVAL THV, a pioneering medical device, has been published by The Lancet This trial proves India’s capability to set new standards in cardiovascular care, and revolutionises heart valve treatment worldwide. Meril Life Sciences, an India-based global medical device
“Today, India is undertaking a transformative journey, one that looks at illness to wellness from a completely new prism. As we delve into the significance of health and hygiene, let us acknowledge India’s remarkable evolution in this realm. The WHO recommends a doctor to population
To train over 1500 people on the life-saving technique of hands-only-CPR India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc (NYSE: MDT) and Fortis Escorts Heart Institute today launched 'Reset the Beat', a nationwide campaign aimed to increase awareness on sudden cardiac arrest
